Since recombinant MCP-1 significantly upregulated pro-survival signaling, these results contribute to the evidence that endogenous MCP-1 enhances cancer malignancy and survival independent of tumor-associated cells, although a few benign cell lines like HaCaT were reported to have many MCP-1 transcripts [36]. This evidence concerns the gene CCL2 and neoplasm.